TABLE OF CONTENTS
1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.3 OVERVIEW OF GLOBAL MOBILE CARDIAC TELEMETRY (MCT) MARKET 23
1.4 LIMITATIONS 25
1.5 MARKETS COVERED 25
2 MARKET SEGMENTATION 28
2.1 MARKETS COVERED 28
2.2 GLOBAL MOBILE CARDIAC TELEMETRY (MCT) MARKET: GEOGRAPHICAL SCOPE 29
2.3 YEARS CONSIDERED FOR THE STUDY 30
2.4 CURRENCY AND PRICING 30
2.5 DBMR TRIPOD DATA VALIDATION MODEL 31
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 34
2.7 DBMR MARKET POSITION GRID 35
2.8 DBMR VENDOR SHARE ANALYSIS 36
2.9 MULTIVARIATE MODELING 37
2.10 PRODUCTS LIFELINE CURVE 37
2.11 SECONDARY SOURCES 38
2.12 ASSUMPTIONS 38
3 MARKET OVERVIEW 39
3.1 DRIVERS 41
3.1.1 GROWING NUMBER OF CARDIAC DISEASES 41
3.1.2 INCREASING TECHNOLOGICAL ADVANCEMENT 43
3.1.3 INCREASED DIAGNOSTIC YIELD OF THE MCT DEVICES 44
3.1.4 HIGH REIMBURSEMENT POLICIES 45
3.2 RESTRAINTS 46
3.2.1 AVAILABILITY OF ALTERNATIVE METHODS 46
3.3 OPPORTUNITIES 47
3.3.1 GROWING STRATEGIC RELATIONSHIPS FOR DEVELOPMENT OF MCT 47
3.3.2 GROWING DEMAND OF PREDICTIVE AND PERSONALIZED HEALTHCARE SOLUTIONS. 47
3.4 CHALLENGES 48
3.4.1 LACK OF SKILLED LABOUR FORCE 48
?
4 EXECUTIVE SUMMARY 49
4.1 GLOBAL MOBILE CARDIAC TELEMETRY (MCT) MARKET: SEGMENTATION 50
4.2 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL MOBILE CARDIAC TELEMETRY (MCT) MARKET AND IS ESTIMATED TO BE INCREASING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2019 TO 2026 51
5 PREMIUM INSIGHTS 52
5.1 NORTH AMERICA IS THE MAXIMUM GROWING IS THE MOST PROFITABLE REVENUE POCKETS FOR GLOBAL MOBILE CARDIAC TELEMETRY (MCT) MARKET IN THE FORECAST PERIOD OF 2019 TO 2026 53
5.2 GLOBAL MOBILE CARDIAC TELEMETRY (MCT) MARKET, BY PRODUCT SPECIFICATION 54
5.2.1 HOLTER MONITORS 54
5.2.2 EVENT RECORDER 55
5.2.3 SENSOR 55
5.2.4 BATTERY CHARGER 55
5.2.5 WIRELESS TRANSMITTER 56
5.2.6 REMOTELY ACCESS DEVICE/ CONTROL DEVICE 56
5.3 PARENT MARKET ANALYSIS 57
5.3.1 CARDIAC MONITORING MODALITIES MARKET SHARE, BY VOLUME, OF 2018 57
5.3.2 CARDIAC MONITORING MODALITIES, BY MARKET SHARE, (USD) 2018 57
5.3.3 MEDICARE PRICING PER PROCEDURE IN USD 58
6 GLOBAL MOBILE CARDIAC TELEMETRY (MCT) MARKET, BY TECHNOLOGY 59
6.1 OVERVIEW 60
6.2 LEAD BASED 61
6.3 3 LEADS 62
6.4 5 LEADS 62
6.5 MULTI-LEADS 62
6.6 PATCH BASED 62
6.7 SINGLE LEAD 63
6.8 3 LEADS 63
6.9 MULTI-LEADS 63
7 GLOBAL MOBILE CARDIAC TELEMETRY (MCT) MARKET, BY TYPE 64
7.1 OVERVIEW 65
7.2 MULTI-CHANNEL 66
7.3 SINGLE -CHANNEL 67
?
8 GLOBAL MOBILE CARDIAC TELEMETRY (MCT) MARKET,
BY CELLULAR CONNECTION 68
8.1 OVERVIEW 69
8.2 WIRELESS (WIFI) 70
8.3 BLUETOOTH (BT) 70
9 GLOBAL MOBILE CARDIAC TELEMETRY (MCT) MARKET, BY END USER 72
9.1 OVERVIEW 73
9.2 HOME HEALTHCARE 74
9.3 HOSPITALS 74
9.4 INDEPENDENT DIAGNOSTIC TESTING FACILITY (IDTF) 75
9.5 CARDIAC CENTER 76
9.6 AMBULATORY SURGICAL CENTERS 76
10 GLOBAL MOBILE CARDIAC TELEMETRY (MCT) MARKET, BY GEOGRAPHY 78
10.1 OVERVIEW 79
10.2 NORTH AMERICA 84
10.2.1 U.S. 89
10.2.2 CANADA 91
10.2.3 MEXICO 93
10.3 EUROPE 95
10.3.1 GERMANY 100
10.3.2 FRANCE 102
10.3.3 U.K. 104
10.3.4 ITALY 106
10.3.5 SPAIN 108
10.3.6 POLAND 110
10.3.7 NETHERLANDS 112
10.3.8 SWITZERLAND 114
10.3.9 RUSSIA 116
10.3.10 BELGIUM 118
10.3.11 TURKEY 120
10.3.12 REST OF EUROPE 122
10.4 ASIA-PACIFIC 123
10.4.1 CHINA 128
10.4.2 JAPAN 130
10.4.3 INDIA 132
10.4.4 AUSTRALIA 134
10.4.5 SOUTH KOREA 136
10.4.6 MALAYSIA 138
10.4.7 THAILAND 140
10.4.8 SINGAPORE 142
10.4.9 INDONESIA 144
10.4.10 PHILIPPINES 146
10.4.11 REST OF ASIA-PACIFIC 148
10.5 SOUTH AMERICA 149
10.5.1 BRAZIL 154
10.5.2 REST OF SOUTH AMERICA 156
10.6 MIDDLE EAST & AFRICA 157
10.6.1 SOUTH AFRICA 162
10.6.2 REST OF MIDDLE EAST & AFRICA 164
11 GLOBAL MOBILE CARDIAC TELEMETRY (MCT) MARKET, COMPANY LANDSCAPE 165
11.1 COMPANY SHARE ANALYSIS: GLOBAL 165
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 166
11.3 COMPANY SHARE ANALYSIS: EUROPE 167
11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 168
12 COMPANY PROFILE 169
12.1 BIOTELEMETRY, INC. 169
12.1.1 COMPANY SNAPSHOT 169
12.1.2 REVENUE ANALYSIS 169
12.1.3 COMPANY SHARE ANALYSIS 170
12.1.4 PRODUCT PORTFOLIO 170
12.1.5 RECENT DEVELOPMENTS 170
12.2 IRHYTHM TECHNOLOGIES, INC. 171
12.2.1 COMPANY SNAPSHOT 171
12.2.2 REVENUE ANALYSIS 171
12.2.3 COMPANY SHARE ANALYSIS 172
12.2.4 PRODUCT PORTFOLIO 172
12.2.5 RECENT DEVELOPMENT 172
12.3 HILL-ROM SERVICES INC. 173
12.3.1 COMPANY SNAPSHOT 173
12.3.2 REVENUE ANALYSIS 173
12.3.3 COMPANY SHARE ANALYSIS 174
12.3.4 PRODUCT PORTFOLIO 174
12.3.5 RECENT DEVELOPMENTS 174
?
12.4 ASAHI KASEI CORPORATION 175
12.4.1 COMPANY SNAPSHOT 175
12.4.2 REVENUE ANALYSIS 175
12.4.3 COMPANY SHARE ANALYSIS 176
12.4.4 PRODUCT PORTFOLIO 176
12.4.5 RECENT DEVELOPMENT 176
12.5 APPLIED CARDIAC SYSTEMS, INC. 177
12.5.1 COMPANY SNAPSHOT 177
12.5.2 PRODUCT PORTFOLIO 177
12.5.3 RECENT DEVELOPMENT 177
12.6 BIOTRICITY 178
12.6.1 COMPANY SNAPSHOT 178
12.6.2 PRODUCT PORTFOLIO 178
12.6.3 RECENT DEVELOPMENT 178
12.7 BIOTRONIK, INC 179
12.7.1 COMPANY SNAPSHOT 179
12.7.2 PRODUCT PORTFOLIO 179
12.7.3 RECENT DEVELOPMENT 179
12.8 BITTIUM 180
12.8.1 COMPANY SNAPSHOT 180
12.8.2 REVENUE ANALYSIS 180
12.8.3 PRODUCT PORTFOLIO 181
12.8.4 RECENT DEVELOPMENT 181
12.9 CARDIAC INSIGHT INC. 182
12.9.1 COMPANY SNAPSHOT 182
12.9.2 PRODUCT PORTFOLIO 182
12.9.3 RECENT DEVELOPMENT 182
12.10 CORVITALS, INC 183
12.10.1 COMPANY SNAPSHOT 183
12.10.2 PRODUCT PORTFOLIO 183
12.10.3 RECENT DEVELOPMENT 183
12.11 MEDICALGORITHMICS 184
12.11.1 COMPANY SNAPSHOT 184
12.11.2 REVENUE ANALYSIS 184
12.11.3 PRODUCT PORTFOLIO 185
12.11.4 RECENT DEVELOPMENTS 185
12.12 MEDICOMP INC 186
12.12.1 COMPANY SNAPSHOT 186
12.12.2 PRODUCT PORTFOLIO 186
12.12.3 RECENT DEVELOPMENT 186
12.13 NATIONAL CARDIAC INC. 187
12.13.1 COMPANY SNAPSHOT 187
12.13.2 PRODUCT PORTFOLIO 187
12.13.3 RECENT DEVELOPMENT 187
12.14 PREVENTICE SOLUTIONS, INC. 188
12.14.1 COMPANY SNAPSHOT 188
12.14.2 PRODUCT PORTFOLIO 188
12.14.3 RECENT DEVELOPMENTS 188
12.15 THE SCOTTCARE CORPORATION 189
12.15.1 COMPANY SNAPSHOT 189
12.15.2 PRODUCT PORTFOLIO 189
12.15.3 RECENT DEVELOPMENTS 190
13 QUESTIONNAIRE 191
14 RELATED REPORTS 194